Independent Financial Group LLC Takes $490,000 Position in Tenet Healthcare Corporation $THC

Independent Financial Group LLC purchased a new stake in Tenet Healthcare Corporation (NYSE:THC) during the 1st quarter, Holdings Channel reports. The firm purchased 2,597 shares of the company’s stock, valued at approximately $490,000.

Several other hedge funds and other institutional investors have also made changes to their positions in THC. Triumph Capital Management bought a new position in shares of Tenet Healthcare in the third quarter worth $25,000. Activest Wealth Management bought a new position in Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter worth about $29,000. Meeder Asset Management Inc. boosted its holdings in shares of Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares in the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare during the second quarter worth approximately $35,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is owned by corporate insiders.

Tenet Healthcare Price Performance

NYSE THC opened at $199.85 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21. The company has a market cap of $17.22 billion, a PE ratio of 10.39, a PEG ratio of 1.62 and a beta of 1.27. The stock’s 50-day moving average price is $184.43 and its two-hundred day moving average price is $197.37.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Friday, July 24th. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.63 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period last year, the company posted $4.02 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, analysts predict that Tenet Healthcare Corporation will post 17.5 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on THC. Robert W. Baird dropped their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Morgan Stanley set a $254.00 price target on shares of Tenet Healthcare in a report on Friday, May 1st. Wall Street Zen cut shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, July 18th. Weiss Ratings downgraded shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Finally, Wells Fargo & Company lifted their price target on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Seventeen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $244.84.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported second-quarter EPS of $6.12, well above consensus, and revenue of $5.63 billion, also topping estimates, signaling stronger-than-expected operating performance. Article Title
• Positive Sentiment: The company raised FY 2026 guidance to EPS of $20.30-$21.69, above Wall Street expectations, which suggests management sees continued earnings strength ahead. Article Title
• Positive Sentiment: Investor optimism was also supported by Tenet’s improving credit profile and recent analyst sentiment, which had already set up the stock for a strong move into earnings. Article Title
• Neutral Sentiment: Analysts continue to view the stock favorably overall, with a consensus “Moderate Buy” rating, though some recent commentary has been more cautious on valuation. Article Title

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.